livehealth.store

Mylan recalls

Mylan has 5 recalls on record with the FDA and USDA, the earliest in 2012 and the latest reported on 1 Feb 2017. The most frequent reason is packaging defects.

Total recalls5since 2012

Last 12 months0reported

Class I00% of total

Ongoing0latest 1 Feb 2017

Recalls per month, last 24 months

click a bar for that month

0Nov '24 0 0 0Feb 0 0 0May 0 0 0Aug 0 0 0Nov 0 0 0Feb 0 0 0May 0 0 0Aug 0 0

Severity split

Class I 0 0%Class II 5 100%Class III 0 0%

Why mylan is recalled

By year

2017480%
2012120%

All mylan recalls, newest first

5 total

Reported	Class	Recall	Company	Reason	Where
1 Feb 2017Drug	CLASS II	Temozolomide Capsules, 140 mg recalled by Mylan	Mylan	Packaging Defects	Nationwide
1 Feb 2017Drug	CLASS II	Temozolomide Capsules, 180 mg recalled by Mylan	Mylan	Packaging Defects	Nationwide
1 Feb 2017Drug	CLASS II	Temozolomide Capsules, 250 mg recalled by Mylan	Mylan	Other	Nationwide
1 Feb 2017Drug	CLASS II	Temozolomide Capsules, 100 mg recalled by Mylan	Mylan	Packaging Defects	Nationwide
5 Dec 2012Drug	CLASS II	Tacrolimus Capsules 0.5 mg recalled by MylanTacrolimus	Mylan	Potency & Assay	PR

About this list

Records come from FDA enforcement reports and USDA FSIS notices, grouped by normalised name. A company operating under several names may appear more than once.